CDK4/6 Inhibitor research hub

Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors

This study aims to understand why anti-cancer drugs called kinase inhibitors have different side effects in people. By looking at genes and blood markers, researchers hope to predict who might have unwanted reactions or not respond well to treatment, especially for breast cancer.